Original Query: ALL
Previous Study | Return to List | Next Study

Safety & Efficacy of Lamivudine & Tenofovir to Lower Plasma Level of Viral RNA in Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01528865
Recruitment Status : Withdrawn (Funding was removed.)
First Posted : February 8, 2012
Last Update Posted : March 11, 2016
Gilead Sciences
Information provided by (Responsible Party):
University of Michigan Cancer Center

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : August 2017
  Study Completion Date : No date given